Related Experiment Videos
[Thromboembolic disease: prevention with low-molecular weight heparin in general surgery. Preliminary results]
F Pietrelli1, T Renzoni, C Cicoli
1Servizio di Anestesia, Rianimazione, USL n. 6, Ospedale Civile, Fossombrone, Pesaro.
Nine patients undergoing surgery lasting more than 45 minutes were included in the study. They received weekly anti-thromboembolic treatment with parnaparin (INN). Patients did not present thromboembolic complications following clinical and instrumental examination. Blood loss remained within the norm and no collateral effects were observed.
Nine patients undergoing surgery lasting more than 45 minutes were included in the study. They received weekly anti-thromboembolic treatment with parnaparin (INN). Patients did not present thromboembolic complications following clinical and instrumental examination. Blood loss remained within the norm and no collateral effects were observed.